Nasa Sinnott-Armstrong

Assistant Professor

Fred Hutch Cancer Center
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Fibromyalgia is a common and debilitating chronic pain syndrome of poorly understood etiology. Here, we conduct a multi-ancestry genome-wide association study meta-analysis across 2,563,755 individuals (54,629 cases and 2,509,126 controls) from 11 cohorts, identifying the first 26 risk loci for fibromyalgia. The strongest association was with a coding variant in HTT , the causal gene for Huntington’s disease. Gene prioritization implicated the HTT regulator GPR52 , as well as diverse genes with neural roles, including CAMKV , DCC , DRD2 / NCAM1 , MDGA2 , and CELF4 . Fibromyalgia heritability was exclusively enriched within brain tissues and neural cell types. Fibromyalgia showed strong, positive genetic correlation with a wide range of chronic pain, psychiatric, and somatic disorders, including genetic correlations above 0.7 with low back pain, post-traumatic stress disorder and irritable bowel syndrome. Despite large sex differences in fibromyalgia prevalence, the genetic architecture of fibromyalgia was nearly identical between males and females. This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities.

Year:

2025

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a common, poorly understood disease that has no effective treatments, and has long been underserved by scientific research and national health systems. It is a sex-biased disease towards females that is often triggered by an infection, and its hallmark symptom is post-exertional malaise. People with ME/CFS often report their symptoms being disbelieved. The biological mechanisms causing ME/CFS remain unclear. We recruited 21,620 ME/CFS cases and performed genome-wide association studies (GWAS) for up to 15,579 cases and 259,909 population controls with European genetic ancestry. In these GWAS, we discovered eight loci that are significantly associated with ME/CFS, including three near BTN2A2, OLFM4 , and RABGAP1L genes that act in the response to viral or bacterial infection. Four of the eight loci ( RABGAP1L, FBXL4, OLFM4, CA10 ) were associated at p < 0.05 with cases ascertained using post-exertional malaise and fatigue in the UK Biobank and the Netherlands biobank Lifelines. We found no evidence of sex-bias among discovered associations, and replicated in males two genetic signals ( ARFGEF2, CA10 ) discovered in females. The ME/CFS association near CA10 colocalises with a known association to multisite chronic pain. We found no evidence that the eight ME/CFS genetic signals share common causal genetic variants with depression or anxiety. Our findings suggest that both immunological and neurological processes are involved in the genetic risk of ME/CFS. LAY SUMMARY Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a common, disabling illness. It affects more females than males, and in most cases, starts after an infection. Little is known about the biological mechanisms that cause ME/CFS, despite many attempts to uncover them, and it has no effective treatments. To understand ME/CFS better, our study, DecodeME, compared the DNA of 15,579 people with ME/CFS with the DNA of 259,909 people without ME/CFS, all of European descent. DNA is a molecule that makes up our genes. Our genes make many different molecules called proteins, each of which does very specific things in the body. Finding variations in genes that differ between people with or without a disease can therefore point to what causes it. We found that people with ME/CFS are more likely to carry certain DNA differences in eight regions of their genome, and so these variants tell us about possible biological causes of ME/CFS. However, as these differences are also often found in people without ME/CFS they cannot cleanly separate who is at risk and who is not, and therefore do not provide a definitive test. Most of these regions contain several genes. Our methods did not allow us to conclusively locate the ones most relevant to ME/CFS in each region, but public data allowed us to pick out the most likely ones. Three of the most likely genes produce proteins that respond to an infection. Another likely gene is related to chronic pain. None are related to depression or anxiety. We found nothing to explain why more females than males get ME/CFS. Overall, DecodeME shows that ME/CFS is partly caused by genes related to the immune and nervous systems.

Year:

2025

Social factors of health (SFOH) are critical determinants of human traits but are rarely incorporated into genetic models. Here, we assess how participant-completed SFOH survey data influence heritability estimates and trait variance in 85,963 diverse All of Us participants spanning multiple ancestries and racial identities. We summarized SFOH survey data using multiple correspondence analysis (MCA) into axes representing distinct social dimensions (e.g., social support, perceived stress) and developed a Social Similarity Index (SSI) to capture social environment similarity among individuals. To analyze trait heritability, we used Haseman-Elston (HE) regression for its sensitivity to residual structure. Including SFOH measures as covariates in HE regression models significantly reduced heritability estimates for four of 18 traits, three of which are anthropometric: body mass index, hip circumference, waist circumference, and HDL cholesterol. This suggests that unmodeled social structure can be misattributed to genetic effects. Though several SFOH measures have non-zero heritability when adjusting for three genetic principal components ( h 2 ≈ 0.01 − 0.09), these are reduced to similar estimates when adjusting for seven genetic principal components ( h 2 ≈ 0.01 − 0.02). This convergence across SFOH measures, which capture different social dimensions, indicates that SFOH measures capture population stratification, emphasizing their utility for reducing confounding in heritability estimates. SFOH measures were also associated with trait variance, with anthropometric traits—those with reduced heritability—exhibiting the most extensive dispersion effects. This implies that social environment influences trait variability. Our findings highlight the necessity of including social and environmental factors in genetic studies to reduce potential confounding.

Year:

2025

Lyme disease (LD) is an illness caused by the spirochete Borrelia burgdorferi ( B. burgdorferi ). Borrelia is known to disseminate through organs, including the skin, joints, spinal cord, bladder, and heart, leading to Lyme arthritis, neuroborreliosis, and Lyme carditis. While previous studies have investigated the impact of LD on pregnancy in both mice and humans and have found the presence of B. burgdorferi in the uterus of mice, we studied the impact of LD on the non-pregnant female reproductive tract. We use a mouse model for LD and find an ongoing and severe infection of the reproductive tract of female mice, which persists up to 15-months post-inoculation. This infection results in uterine glandular cysts and endometrial hyperplasia as well as vaginal epithelial thickening, polymorphonuclear and mononuclear cell epithelial infiltration, and epithelial desquamation into the vaginal lumen. Strikingly, we find that age has an impact on the extent of gynecologic pathology such that aged female mice (1-year old) that are reproductively senescent have more gynecologic pathology with infection compared to young mice (15-weeks old) when infected for the same length of time. Using large-scale electronic healthcare record data, we report that LD additionally results in increased infection-associated risk of menorrhagia (1.5-fold), miscarriage (1.62-fold), uterine fibroids (1.42-fold), and endometriosis (1.93-fold). Underreporting of gynecological outcomes is pervasive throughout many different infectious diseases, and LD-associated gynecological pathologies may have been similarly underappreciated in the field. This work suggests that further study of the female reproductive tract and the effects of B. burgdorferi infection therein will help clarify and expand the knowledge of myriad LD outcomes. Graphical abstract

Year:

2025

Evening chronotypes (a.k.a. night-owls) are held to be at greater risk for psychiatric disorders. This is postulated to be due to delayed circadian timing increasing the likelihood of circadian misalignment in an early-oriented society. Circadian misalignment is known to heighten sleep inertia, the difficulty transitioning from sleep to wake characterized by low arousal and cognitive impairment, and evening chronotypes experience greater sleep inertia. Therefore, difficulty awakening may explain the relationship between evening chronotype and psychiatric disorders by acting as a biomarker of circadian misalignment. In analyzing the longitudinal incidence of psychiatric disorders in the UK Biobank (n = 496,820), we found that evening chronotype predicted increased incidence of major depressive disorder, schizophrenia, generalized anxiety disorder and bipolar disorder. Crucially, this effect was dependent on sleep inertia, which was a much stronger predictor of these disorders, such that evening types without sleep inertia were at no higher risk as compared to morning types. Longitudinal analyses of suicide and depressed mood (CES-D score) in the Older Finnish Twin Cohort (n = 23,854) replicated this pattern of results. Twin and genome-wide association analyses of difficulty awakening identified the trait to be heritable (Twin H2 = 0.40; SNP h2 = 0.08), enriched for circadian rhythms genes and have substantial shared genetic architecture with chronotype. Marginal and conditional Mendelian randomization analyses mirrored the epidemiological results, such that the causal effect of evening chronotype on psychiatric disorders was driven by shared genetic architecture with difficulty awakening. In contrast, difficult awakening was strongly causally associated with psychiatric disorders independently of chronotype. Psychiatric disorders were only weakly reverse causally linked to difficult awakening. Collectively, these results challenge the notion that evening chronotype is a risk factor for psychiatric disorders per se, suggesting instead that evening types are at greater risk for psychiatric disorders due to circadian misalignment, for which sleep inertia may be acting as a biomarker.

Year:

2024

Circadian rhythms not only coordinate the timing of wake and sleep but also regulate homeostasis within the body, including glucose metabolism. However, the genetic variants that contribute to temporal control of glucose levels have not been previously examined. Using data from 420,000 individuals from the UK Biobank and replicating our findings in 100,000 individuals from the Estonian Biobank, we show that diurnal serum glucose is under genetic control. We discover a robust temporal association of glucose levels at the Melatonin receptor 1B ( MTNR1B) (rs10830963, P = 1e-22) and a canonical circadian pacemaker gene Cryptochrome 2 ( CRY2) loci (rs12419690, P = 1e-16). Furthermore, we show that sleep modulates serum glucose levels and the genetic variants have a separate mechanism of diurnal control. Finally, we show that these variants independently modulate risk of type 2 diabetes. Our findings, together with earlier genetic and epidemiological evidence, show a clear connection between sleep and metabolism and highlight variation at MTNR1B and CRY2 as temporal regulators for glucose levels.

Year:

2024

Collaborators (27)

Hanna Ollila

University of Helsinki

FINLAND
View details

Ava Khamseh

Reader (Associate Professor) in Biomedical AI

University of Edinburgh

UNITED KINGDOM
View details

Renato Polimanti

Yale University School of Medicine

UNITED STATES
View details

Jonathan K Pritchard

Stanford University

UNITED STATES
View details

Søren Brunak

Professor of Disease Systems Biology, Research Director

Københavns Universitet

DENMARK
View details

David van Heel

Professor

Queen Mary University of London

UNITED KINGDOM
View details

Priit Palta

Professor of Translational Genomics

University of Tartu

ESTONIA
View details

Christina Mikkelsen

-

DENMARK
View details

Sisse Rye Ostrowski

Københavns Universitet

DENMARK
View details

Frances Williams

King’s College London

UNITED KINGDOM
View details

Stephanie Zellers

University of Helsinki

FINLAND
View details

Shaila Musharoff

Assistant Professor

Cornell University

UNITED STATES
View details

Lea Urpa

University of Helsinki

FINLAND
View details

Oona Shigeno Risse-Adams

Cornell University

UNITED STATES
View details

Martin Rutter

Professor of Cardiometabolic Medicine

The University of Manchester

UNITED KINGDOM
View details

Christian Erikstrup

Chair Professor

Aarhus University

DENMARK
View details

Andrew Bretherick

Senior Lecturer in Molecular Psychiatry

University of Edinburgh

UNITED KINGDOM
View details

Chris P Ponting

Chair, Medical Bioinformatics

University of Edinburgh

UNITED KINGDOM
View details

Chad Brummett

Bert N. LaDu Professor

University of Michigan

UNITED STATES
View details

Jacqueline Lane

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Hassan Dashti

Assistant Professor

Broad Institute

UNITED STATES
View details

Michal Caspi Tal

Principal Scientist

Massachusetts Institute of Technology

UNITED STATES
View details

Thomas Folkmann Hansen

Professor

Technical University of Denmark

DENMARK
View details

Richa Saxena

Professor of Anaesthesia

Harvard Medical School

UNITED STATES
View details

Ole Birger Pedersen

Professor

Zealand University Hospital

DENMARK
View details

Jaakko Kaprio

Research Director

University of Helsinki

FINLAND
View details

Sean Cain

Professor

Flinders University

AUSTRALIA
View details